Sands Capital Ventures, LLC Long-Term Concentrated

CIK: 0001846444 · Show all filings

Period: Q2 2022 (← Previous) (Next →)

Filing Date: Aug 12, 2022

Total Value ($000): $364,178 (100.0% shares, 0.0% debt)

Holdings (19)

PATH UIPATH INC 19.0%

Value ($000) $69,336 Shares 3,811,779 Est. Cost $60.53 Unrealized -69.1%

— DICE THERAPEUTICS, INC. 13.4%

Value ($000) $48,872 Shares 3,148,970 Est. Cost $32.75 Unrealized —

DASH DOORDASH INC 10.6%

Value ($000) $38,595 Shares 601,454 Est. Cost $191.28 Unrealized -58.5%

NU NU HOLDINGS LTD. 9.4%

Value ($000) $34,172 Shares 9,136,835 Est. Cost $9.82 Unrealized -48.3%

— SAMSARA, INC. 8.3%

Value ($000) $30,296 Shares 2,712,256 Est. Cost $28.11 Unrealized —

SNOW SNOWFLAKE INC 8.2%

Value ($000) $29,845 Shares 214,621 Est. Cost $284.41 Unrealized -44.3%

— KARUNA THERAPEUTICS, INC. 6.0%

Value ($000) $21,873 Shares 172,895 Est. Cost $122.33 Unrealized —

TXG 10X Genomics, Inc. 6.0%

Value ($000) $21,800 Shares 481,770 Est. Cost $51.88 Unrealized 0.0%

— CINCOR PHARMA, INC. 4.9%

Value ($000) $17,898 Shares 950,000 Est. Cost $17.54 Unrealized —

ABOS ACUMEN PHARMACEUTICALS, INC 4.4%

Value ($000) $16,060 Shares 3,417,075 Est. Cost $16.64 Unrealized -77.4%

— OLINK HOLDING AB 2.9%

Value ($000) $10,724 Shares 705,514 Est. Cost $16.68 Unrealized —

MASS 908 DEVICES INC 1.8%

Value ($000) $6,721 Shares 326,427 Est. Cost $33.97 Unrealized -50.5%

TARS TARSUS PHARMACEUTICALS INC 1.0%

Value ($000) $3,796 Shares 260,000 Est. Cost $24.75 Unrealized -39.3%

RGEN REPLIGEN CORP. 1.0%

Value ($000) $3,661 Shares 22,544 Est. Cost $256.54 Unrealized -38.4%

IOT SAMSARA, INC. 1.0%

Value ($000) $3,641 Shares 326,000 Est. Cost $26.05 Unrealized -53.7%

TSHA TAYSHA GENE THERAPIES INC 0.7%

Value ($000) $2,697 Shares 724,873 Est. Cost $19.01 Unrealized -79.1%

CADL CANDEL THERAPEUTICS, INC 0.7%

Value ($000) $2,630 Shares 811,737 Est. Cost $8.29 Unrealized -51.7%

— SPRUCE BIOSCIENCES INC 0.4%

Value ($000) $1,369 Shares 787,007 Est. Cost $6.01 Unrealized —

ABSI ABSCI CORP. 0.1%

Value ($000) $192 Shares 57,804 Est. Cost $19.41 Unrealized -74.4%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
PATH	UIPATH INC	3,811,779	$69,336	19.0%	$60.53	-69.1%	COM CL A	90364P105
—	DICE THERAPEUTICS, INC.	3,148,970	$48,872	13.4%	$32.75	—	COM	23345J104
DASH	DOORDASH INC	601,454	$38,595	10.6%	$191.28	-58.5%	COM CL A	25809K105
NU	NU HOLDINGS LTD.	9,136,835	$34,172	9.4%	$9.82	-48.3%	COM CL A	G6683N103
—	SAMSARA, INC.	2,712,256	$30,296	8.3%	$28.11	—	COM CL B	FDS1Q2O30
SNOW	SNOWFLAKE INC	214,621	$29,845	8.2%	$284.41	-44.3%	COM CL A	833445109
—	KARUNA THERAPEUTICS, INC.	172,895	$21,873	6.0%	$122.33	—	COM	48576A100
TXG	10X Genomics, Inc.	481,770	$21,800	6.0%	$51.88	0.0%	COM CL A	88025U109
—	CINCOR PHARMA, INC.	950,000	$17,898	4.9%	$17.54	—	COM	17240Y109
ABOS	ACUMEN PHARMACEUTICALS, INC	3,417,075	$16,060	4.4%	$16.64	-77.4%	COM	00509G209
—	OLINK HOLDING AB	705,514	$10,724	2.9%	$16.68	—	COM	680710100
MASS	908 DEVICES INC	326,427	$6,721	1.8%	$33.97	-50.5%	COM	65443P102
TARS	TARSUS PHARMACEUTICALS INC	260,000	$3,796	1.0%	$24.75	-39.3%	COM	87650L103
RGEN	REPLIGEN CORP.	22,544	$3,661	1.0%	$256.54	-38.4%	COM	759916109
IOT	SAMSARA, INC.	326,000	$3,641	1.0%	$26.05	-53.7%	COM CL A	79589L106
TSHA	TAYSHA GENE THERAPIES INC	724,873	$2,697	0.7%	$19.01	-79.1%	COM	877619106
CADL	CANDEL THERAPEUTICS, INC	811,737	$2,630	0.7%	$8.29	-51.7%	COM	137404109
—	SPRUCE BIOSCIENCES INC	787,007	$1,369	0.4%	$6.01	—	COM	85209E109
ABSI	ABSCI CORP.	57,804	$192	0.1%	$19.41	-74.4%	COM	00091E109